Alert: New Earnings Report (11/2/23)-Cytokinetics Inc (NASDAQ: CYTK).
For its third fiscal quarter (ending September 30), Cytokinetics Inc (NASDAQ: CYTK) has reported E.P.S. of $-1.35 compared to $-1.52 a year ago. This result fell short of the consensus estimate of $-0.78 by $-0.57. […]